Role of cytochrome P450 2C9 and an allelic variant in the 4′-hydroxylation of (R)- and (S)-flurbiprofen
- 1 May 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (9) , 1269-1275
- https://doi.org/10.1016/0006-2952(95)00048-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.Circulation, 1994
- Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9Pharmacogenetics, 1994
- Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liverLife Sciences, 1993
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- Metabolic enantiomeric interactions: The inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarinChirality, 1991
- Stereoselective arylpropionyl‐CoA thioester formation in vitroChirality, 1990
- Stereoselective pharmacokinetics of flurbiprofen in humans and ratsJournal of Pharmaceutical Sciences, 1988
- The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequencesBiochemical Pharmacology, 1988
- Pharmacokinetics of flurbiprofen in man. I. Area/dose relationshipsBiopharmaceutics & Drug Disposition, 1987
- The Disposition and Metabolism of Flurbiprofen in Several Species Including ManXenobiotica, 1978